CoChat

Clinical Improvements From Telemedicine Interventions for Managing Type 2 Diabetes Compared With Usual Care: Systematic Review, Meta-Analysis, and Meta-Regression

Open access
Jiang, Shujie, Gao, Xianru, Diao, Haiqing, Zhang, Yang, Lu, Guangyu, Liu, Xiaoguang, Li, Yuping · 2026 · JMIR mHealth and uHealth

Published version of a preprint

The DOI matches its Crossref record, with a small difference in title or year; 113 of the 113 references it cites were found in a registry or an index; 22 of the 40 sources its claims cite were checked for support.

Abstract

This systematic review and meta-analysis evaluated the clinical effectiveness of various telemedicine interventions compared with usual care in glycemic control, and cardiovascular health in adults with T2DM. A random-effects model was used, analyzing 58 RCTs (13,942 participants) published up to August 2024. The pooled results showed a significant reduction in HbA1c levels in the telemedicine group compared with the control group (MD -0.38, 95% CI -0.49 to -0.27; P < .001). Subgroup analyses by duration revealed significant reductions in short-term and long-term, but not mid-term. Telemedicine delivered by physicians and dietitians showed significantly greater reduction in HbA1c.

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis of 58 RCTs (13,942 adults with type 2 diabetes) found that telemedicine interventions improved HbA1c and several cardiometabolic outcomes compared with usual care. Effects were significant for HbA1c, fasting blood glucose, weight, BMI, and blood pressure, but not for HDL-c or LDL-c.

Key findings

  • Telemedicine significantly reduced HbA1c versus usual care: MD –0.38, 95% CI –0.49 to –0.27; Z=6.94; P<.001, with high heterogeneity (I²=96%).
  • Significant secondary improvements were found for fasting blood glucose (MD –11.29, 95% CI –17.65 to –4.93; P<.001), weight (MD –1.33, 95% CI –2.23 to –0.44; P=.004), BMI (MD –0.43, 95% CI –0.72 to –0.13; P=.004), systolic blood pressure (MD –2.14, 95% CI –3.02 to –1.26; P<.001), and diastolic blood pressure (MD –1.24, 95% CI –2.02 to –0.46; P=.002).
  • No significant between-group differences were found for HDL-c (MD –3.41, 95% CI –2.67 to 9.49; P=.27) or LDL-c (MD –0.69, 95% CI –11.69 to 10.31; P=.90).
  • Subgroup analyses showed significant HbA1c reductions across telemedicine types; interventions delivered by physicians, dietitians, and researchers achieved significant reductions, while those by nurses, pharmacists, medical teams, and coaches did not. Short-term and long-term interventions showed significant HbA1c improvements, but medium-term interventions did not. Meta-regression found no statistically significant moderators.

Methods

  • Systematic review and meta-analysis following PRISMA, registered in PROSPERO (CRD42024608130); searched Embase, PubMed, Scopus, CINAHL, and Web of Science from inception to August 2024 for RCTs comparing telemedicine with usual care in adults with T2DM.
  • Included 58 RCTs with 13,942 participants; primary outcome was HbA1c change, with secondary outcomes including mean glucose, fasting blood glucose, BMI, weight, systolic and diastolic blood pressure, HDL-c, and LDL-c.
  • Random-effects meta-analysis was used; 47 studies contributed to the HbA1c meta-analysis, and 4 studies using 2 telemedicine types yielded 62 intervention groups. Subgroup analyses, meta-regression, Cochrane risk-of-bias assessment, GRADE, publication-bias assessment, and sensitivity analysis were performed.

Limitations

  • The paper states high heterogeneity (I²=96%) likely due to variation in telemedicine content, media, providers, and duration; blinding was not possible; subgroup analyses had limited studies and high heterogeneity; and exclusion of non-English studies may be a source of publication bias.
  • The paper also notes that publication-bias assessment showed borderline Egger significance (t=–1.98; P=.054), and trim-and-fill suggested 14 potentially missing studies, with an adjusted effect size of –0.607 (95% CI –0.800 to –0.414) versus the observed –0.379 (95% CI –0.579 to –0.180), so findings should be interpreted cautiously.
  • Evident from the text: meta-regression did not identify any statistically significant moderators (provider approached significance at P=.084), and risk-of-bias concerns included high risk for blinding of participants/personnel in 30/58 studies (51%), unclear allocation concealment in 37/58 (64%), and high risk from other sources in 20/58 (34%).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2196/70429

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

8 tests recomputed · 1 with the reported and recomputed p on opposite sides of .05

Figures

Figure 1 Flowchart summarizing the process of study selection. HbA1c: glycated hemoglobin; RCT: randomized controlled trial.
Figure 1 Flowchart summarizing the process of study selection. HbA1c: glycated hemoglobin; RCT: randomized controlled trial.CC BY · PubMed Central
Figure 2 RoB assessment: summary plot. RoB: risk of bias.
Figure 2 RoB assessment: summary plot. RoB: risk of bias.CC BY · PubMed Central
Figure 3 Forest plot of the overall meta-analysis of the change in HbA1c between the telemedicine intervention group and the control group (47 studies [28,36-81]). *A study used 2 different telemedicine tools for the intervention, which are used here to differentiate. HbA1c: glycated hemoglobin.
Figure 3 Forest plot of the overall meta-analysis of the change in HbA1c between the telemedicine intervention group and the control group (47 studies [28,36-81]). *A study used 2 different telemedicine tools for the intervention, which are used here to differentiate. HbA1c: glycated hemoglobin.CC BY · PubMed Central
Figure 4 Forest plot of the subgroup meta-analysis of the change in HbA1c by type of telemedicine intervention (46 studies [28,36-42,44-81]). *A study used 2 different telemedicine tools for the intervention, which are used here to differentiate. HbA1c: glycated hemoglobin.
Figure 4 Forest plot of the subgroup meta-analysis of the change in HbA1c by type of telemedicine intervention (46 studies [28,36-42,44-81]). *A study used 2 different telemedicine tools for the intervention, which are used here to differentiate. HbA1c: glycated hemoglobin.CC BY · PubMed Central
Figure 5 Forest plot of the subgroup meta-analysis of the change in HbA1c by telemedicine provider (47 studies [28,36-81]). *A study used 2 different telemedicine tools for the intervention, which are used here to differentiate. HbA1c: glycated hemoglobin.
Figure 5 Forest plot of the subgroup meta-analysis of the change in HbA1c by telemedicine provider (47 studies [28,36-81]). *A study used 2 different telemedicine tools for the intervention, which are used here to differentiate. HbA1c: glycated hemoglobin.CC BY · PubMed Central
Figure 6 Forest plot of the subgroup meta-analysis of the change in HbA1c by duration of telemedicine intervention (47 studies [28,36-81]). *A study used 2 different telemedicine tools for the intervention, which are used here to differentiate. HbA1c: glycated hemoglobin.
Figure 6 Forest plot of the subgroup meta-analysis of the change in HbA1c by duration of telemedicine intervention (47 studies [28,36-81]). *A study used 2 different telemedicine tools for the intervention, which are used here to differentiate. HbA1c: glycated hemoglobin.CC BY · PubMed Central
Figure 7 Funnel plot of effect size versus standard error for change in HbA1c.
Figure 7 Funnel plot of effect size versus standard error for change in HbA1c.CC BY · PubMed Central

Verification

Claims the paper makes

12 Valid · 3 Not valid · 9 Not checked · 70 Own results and interpretations

51 more claims

Create a free account to see all 94 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 20
  • It may state two separate claims as one. 22
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Statistics that don’t add up

Each reported p-value recomputed from its test statistic and degrees of freedom.

1 of 1

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • Doesn’t add upz = 1.1reported p = .002 · recomputed p = .271The two fall on opposite sides of .05

    “Z=1.10, p = .002”

  • Consistentz = 6.94reported p < .001 · recomputed p < .001

    “Z=6.94, p < .001”

  • Consistentz = 3.48reported p < .001 · recomputed p < .001

    “Z=3.48, p < .001”

  • Consistentz = 2.91reported p = .004 · recomputed p = .004

    “Z=2.91, p = .004”

  • Consistentz = 2.84reported p = .004 · recomputed p = .005

    “Z=2.84, p = .004”

5 of 8 · the rest aren’t loaded

3 more recomputed tests

Create a free account to see every test the Stats check recomputed.

See all tests — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 6 · the rest aren’t loaded

1 more finding

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 113 references

Research works printed but not linked: 2

  1. Jantraporn, R, 2019, J Med Assoc Thailand, 102, 523
  2. Mechanic, OJ, 2024, Treasure Island (Fl) Ineligible Companies. Disclosure: Yudy Persaud Declares No Relevant Financial Relationships with Ineligible Companies

Cited by

Metadata

Authors
Jiang, S., Gao, X., Diao, H., Zhang, Y., Lu, G., Liu, X., & Li, Y.
Affiliations
  • Yangzhou University (CN)
  • Northern Jiangsu People's Hospital (CN)
Corresponding author
Li, Yuping
Venue
JMIR mHealth and uHealth
Published
2026-02-18
Volume
14
Pages
e70429
ISSN
2291-5222 (ISSN-L)
OpenAlex
W4414003606
Cited by
6
References
92
Citations by year
2026: 6
FWCI
1.14
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • JMIR mhealth and uhealth (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, telemedicine, glycemic control, HbA1c, fasting blood glucose, cardiovascular risk factors, blood pressure, serum lipids, weight loss, usual care comparison, telehealth intervention, diabetes management, health care access, health information technology, remote patient monitoring, teleconsultation, telecoaching, telepharmacy
MeSH terms
Blood Glucose, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Telemedicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.